** Archer Materials AXE.AX rises 8% to A$0.27; marks biggest intraday pct gain since April 11
** Semiconductor firm signs agreement with UK graphene-based electronics company Paragraf to advance development of Archer's biochip potassium ion sensor to test for chronic kidney disease
** Says deal to be in two stages at total estimated cost of A$450,000 ($288,810)
** About 526,535 shares traded vs the 30-day avg
** Stock trims YTD losses to 53.5%
($1 = A$1.5581)
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.